Vitro Biopharma, Inc. (VTRO)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Vitro Biopharma, Inc. Stock (VTRO) Company Profile

Vitro Biopharma, Inc.

Healthcare (1164)

Biotechnology (681)

(720) 859-4120

4621 TECHNOLOGY DRIVE, GOLDEN

VTRO's Discussions on Twitter

VTRO を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
VTRO Vitro Biopharma, Inc.	0.00	0	1.65M	-5.91M	-3.03M	-0.1707
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

Vitro Biopharma, Inc. (VTRO) 最新ニュース

Vitro Biopharma, Inc. (VTRO) 財務データ

Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma, Inc. Stock (VTRO) Company Profile

VTRO を他の銘柄と比較する

Vitro Biopharma, Inc. (VTRO) 最新ニュース

Dealmaking Quarterly Statistics, Q2 2022 - insights.citeline.com

COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product - Yahoo Finance

Vitro Biopharma Products Advance Pancreatic Cancer Research - ACCESS Newswire

Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous Stem Cell Activation for Therapeutic Benefit - ACCESS Newswire

Best Biotech Stocks to Buy in 2025 - The Motley Fool

Vitro Biopharma Announces Advances in Stem Cell Therapy without Transplants - ACCESS Newswire

Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World

Reviewing Cyclo Therapeutics (NASDAQ:CYTH) and Vitro Diagnostics (OTCMKTS:VODG) - Defense World

Financing Quarterly Statistics, Q4 2024 - Citeline

Vitro Biopharma, Inc. Reports Earnings Results for the Full Year Ended October 31, 2024 - Marketscreener.com

Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter - ACCESS Newswire

Vitro Diagnostics (OTCMKTS:VODG) & Inhibrx (NASDAQ:INBX) Head to Head Review - Defense World

Biopharmaceutical Culture Media Market Insight 2025 is Exhibitin - WICZ

In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace

Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World

6 cultured meat companies making waves - Labiotech.eu

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - Business Wire

Biopharmaceutical Culture Media Industry Trends & Drivers - Economica

Top 5 In-Vitro Diagnostics [IVD] Companies, Worldwide by 2024 - Fortune Business Insights

FDA’s lab-developed test rule could be first test of agency’s power post-Chevron - BioPharma Dive

Vitro Biopharma, Inc. announced that it has received $0.3 million in funding - Marketscreener.com

A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive

New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 - Yahoo Finance

GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - PR Newswire

FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive

21 Atlanta Biotech Companies Making Waves in the Life Sciences Sector - Built In

Fapon Empowers Indian IVD Manufacturers at Medical Fair India 2024 - PR Newswire

Swiss investment firm denies acquisition bid for Boryung Biopharma - KBR

Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc. - PR Newswire

Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments - StockTitan

Siemens Healthineers considering $8 billion sale of in vitro diagnostics unit, announces 300 layoffs - DOTmed HealthCare Business News

Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development - PR Newswire

IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO (VTRO) - Seeking Alpha

Startup aims to make lab-grown human eggs, transforming options for creating families - NPR

VTRO IPO NewsStem cell biotech Vitro Biopharma sets terms for $10 million IPO - renaissancecapital.com

CYPRE’S 3D in Vitro Platform Advances New Insights into the Tumor Microenvironment, Drives Data in 30 Days for Clients - Business Wire

Global Stem Cells Market Research Report 2023: Implications - GlobeNewswire

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF - STAT

Who are the leading innovators in in-vitro T-cell activation for the pharmaceutical industry? - Pharmaceutical Technology

Vitro Biopharma, Inc. announced a financing transaction -January 05, 2023 - Marketscreener.com

In Vitro Glycoengineering – Suitability For BioPharma Manufacturing - BioProcess Online

SeQure Dx Emerges From Stealth Mode to Fulfill the Promise of On-Target Gene Editing Therapies for Biopharma Partners, Physicians, and Patients - Business Wire

FUJIFILM Irvine Scientific PRIME-XV Stem FreezIS DMSO-Free Cryopreservation Medium to be Used in FDA-Authorized Clinical Trial - Business Wire

Is Vitro Biopharma Inc. IPO a Good Buy? - Benzinga

Vitro Biopharma Names Chris Furman Chief Executive Officer - Yahoo Finance

Understanding the promising opportunities for in-vitro diagnostics companies in the next decade - IQVIA

The 10 most innovative biotech companies in 2022 - Fast Company

Business of Biotechniques 2022 - BioTechniques

Schrödinger picks up protein crystallographer XTAL BioStructures - Fierce Biotech

Can-Fite says Piclidenoson destroys pathological skin cells in vitro - Seeking Alpha

43 Top Biopharma Startups and Companies in Germany - EU-Startups

Vitro Biopharma, Inc. (VTRO) 財務データ

収益

当期純利益

現金流量

EPS

VTROに似た銘柄